☆ 4.6 Letter

The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 94, Issue 2, Pages E58-E61

Publisher

WILEY
DOI: 10.1002/ajh.25361

Keywords

-

Categories

Hematology

Funding

  1. NHLBI NIH HHS [U01 HL143402] Funding Source: Medline
  2. Janssen Scientific Affairs, LLC. Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.